Cargando…
Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment
Triple-negative breast cancer (TNBC) is characterized by aggressive behavior and limited treatment options, necessitating the identification of novel therapeutic targets. In this study, we investigated the clinical significance of connective tissue growth factor (CTGF) as a prognostic marker and exp...
Autores principales: | Lee, Jeong Hee, Kim, Jongsu, Kim, Hong Sook, Kang, Young Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671558/ https://www.ncbi.nlm.nih.gov/pubmed/38003505 http://dx.doi.org/10.3390/ijms242216307 |
Ejemplares similares
-
Kahweol decreases hepatic fibrosis by inhibiting the expression of connective tissue growth factor via the transforming growth factor-beta signaling pathway
por: Seo, Hye-Young, et al.
Publicado: (2017) -
Kahweol Exerts Skin Moisturizing Activities by Upregulating STAT1 Activity
por: Chen, Hongxi, et al.
Publicado: (2021) -
Cafestol and Kahweol: A Review on Their Bioactivities and Pharmacological Properties
por: Ren, Yaqi, et al.
Publicado: (2019) -
Recent Updates on the Functional Impact of Kahweol and Cafestol on Cancer
por: Eldesouki, Salma, et al.
Publicado: (2022) -
Kahweol, a Diterpenoid Molecule, Inhibits CTGF-Dependent Synthetic Phenotype Switching and Migration in Vascular Smooth Muscle Cells
por: Lee, Jeong Hee, et al.
Publicado: (2021)